Literature DB >> 11822352

The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats.

Patricia R V Calvente1, Carlos C S Araujo, Marcelo Bergamo, Vanessa C Abilio, Vânia D'Almeida, Rosana De A Ribeiro, Filho Roberto Frussa.   

Abstract

The effects of a previous long-term administration of the mitochondrial toxin 3-nitropropionic acid were studied on an animal model of tardive dyskinesia, i.e., the frequency of spontaneous tongue protrusions in rats repeatedly treated with reserpine. 3-Nitropropionic acid (10 or 15 mg/kg i.p., every other day for 17 days) potentiated the increase in tongue-protrusion frequency induced by reserpine (1 mg/kg, s.c., every other day for 3 days) but did not modify reserpine-induced increase in immobility duration and decrease in locomotion frequency. These results support the notion that neurotoxic events are associated with the development of tardive dyskinesia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822352     DOI: 10.1016/s0278-5846(01)00255-x

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  L-Theanine Decreases Orofacial Dyskinesia Induced by Reserpine in Rats.

Authors:  Hung-Sheng Soung; Mao-Hsien Wang; Kuo-Chi Chang; Cheng-Neng Chen; Yi Chang; Chih-Chuan Yang; Hsiang-Chien Tseng
Journal:  Neurotox Res       Date:  2018-04-09       Impact factor: 3.911

2.  Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi.

Authors:  Rupali A Patil; Yogesh A Hiray; Sanjay B Kasture
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

3.  Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.

Authors:  Fernanda F Peres; Raquel Levin; Mayra A Suiama; Mariana C Diana; Douglas A Gouvêa; Valéria Almeida; Camila M Santos; Lisandro Lungato; Antônio W Zuardi; Jaime E C Hallak; José A Crippa; D'Almeida Vânia; Regina H Silva; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.